It is about improving metabolic health, controlling appetite, preserving muscle, building better habits, and maintaining progress after the first few weeks or months
A1C reduction comparison A network meta-analysis published in BMC Endocrine Disorders in 2024, analyzing 26 clinical studies, found the following A1C reductions compared to placebo: Tirzepatide 15mg: -2.24% A1C reduction Tirzepatide 10mg: -1.99% A1C reduction Tirzepatide 5mg: -1.82% A1C reduction Liraglutide 1.8mg: approximately -1.3% A1C reduction Liraglutide 1.2mg: -1.23% A1C reduction At the highest respective doses, tirzepatide reduces A1C by nearly twice as much as liraglutide
Clinical Genetics
H.et al (2013)
Los datos humanos citados por el grupo de origen (seguimientos de longevidad/mortalidad, indicaciones retinianas) corresponden mayormente a fuentes primarias antiguas en ruso y no estn corroborados por ensayos controlados, registrados y revisados por pares
Gastrointestinal (GI) adverse eventsparticularly nausea, vomiting, diarrhea, and constipationare the most common side effects, generally emerging during dose escalation and resolving over time
%20(1).png)
